Takeda

Pharmaceuticals

Active
Chuo City, Japan Founded 1891
Total raised
Stage
Founded
1891
Headcount
72
HQ
Chuo City, Japan
Sector

About

Takeda is a global pharmaceutical company based in Japan. The company conducts research and development, manufacturing, and marketing of pharmaceutical products in various therapeutic areas, including oncology, gastroenterology, and central nervous system disorders. Takeda is also involved in the production of vaccines and has a significant presence in the global pharmaceutical market.

Takeda Pharmaceutical Company has a presence in Israel, mainly through its subsidiary Takeda Israel Ltd. The company conducts research and development activities in the country, focusing on areas such as oncology, neuroscience, and rare diseases. Takeda Israel also works with local partners and academic institutions to advance research and development in these areas. Additionally, Takeda Israel is involved in the commercialization and distribution of Takeda's products in Israel.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When did Takeda become a publicly traded company on the Tokyo Stock Exchange?
Takeda became public on the Tokyo Stock Exchange (TYO) in December 2013, trading under the ticker 4502.
When did Takeda conduct its IPO on the New York Stock Exchange?
Takeda conducted an IPO on the New York Stock Exchange (NYSE) in December 2018, with the ticker TAK.
What was a significant development for Takeda in Israel in August 2022?
In August 2022, Y-mAbs and Takeda announced marketing authorization in Israel for DANYELZA® (naxitamab-gqgk) for Neuroblastoma.
When did Takeda establish its presence in Israel?
Takeda established its presence in Israel in November 2013.
What recognition did Takeda Israel receive in April 2018?
In April 2018, Takeda Israel was awarded the 'Best Place to Work in Israel for 2018'.
What was reported about Takeda's plans in Israel in May 2015?
In May 2015, it was reported that Japan-based Takeda was preparing for a strategic investment in Israel.
What is Takeda's primary focus for research and development activities in Israel?
Takeda Israel focuses its research and development activities on areas such as oncology, neuroscience, and rare diseases, often collaborating with local partners and academic institutions.
What is the employee count for Takeda in Israel?
Takeda Israel has between 51 and 200 employees, with an exact count of 72.

Tags

neurosciencepharmaceuticalsgastroenterologyoncologyrare-diseasesinnovation-center